EUVIMEDEUVIMED entdecken
Crossref

MAGEA6 Promoted Gastric Cancer Progression by Activating Mitophagy

Feifei Shen, Xiaohuan Li iD, Haili Qi, Wei Yu, Yuan Liu, Zhanping Guo

Molecular Carcinogenesis · 06.10.2026

DOI: 10.1002/mc.70189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 06.10.2026. Verfasst von Feifei Shen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endoscopic Diagnosis and Treatment, Xinxiang Central Hospital, Xinxiang, China. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Clinical efficacy and prognosis of endoscopic mucosal dissection in the treatment of early gastric cancer and precancerous lesions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma‐associated antigen A6 (MAGEA6) is aberrantly expressed in several cancers and exhibits oncogenic activity. This study aimed to investigate the function and underlying mechanisms of MAGEA6 in gastric cancer (GC). The TCGA dataset was utilized in this study to evaluate MAGEA6 expression in GC. Subsequently, the Transwell assay, EDU labeling, and the Cell Counting Kit‐8 were employed to assess the effects of MAGEA6 on the migration and proliferation of GC cells. Mitochondrial autophagy and activity examined using mito‐Keima staining, transmission electron microscopy, and the JC‐1 assay.We found that MAGEA6 was highly expressed in GC patient tissues and cell lines. Overexpression of MAGEA6 enhanced the migratory and proliferative capabilities of GC cells. Additionally, MAGEA6 overexpression promoted mitophagy and prevented mitochondrial collapse. Mechanistically, MAGEA6 activated the PINK1/PRKN pathway by upregulating the protein expression of S100A9, a mechanism closely associated with the pro‐cancer phenotype of MAGEA6.The MAGEA6/S100A9/PINK1/PRKN mitophagy pathway is a potential mechanism that promotes GC progression. It may serve as a promising target for GC therapy.

Schlagwörter

Stichwörter der Autor:innen

MAGEA6gastric cancermitophagy

Autor:innen und Institutionen

  • Department of Endoscopic Diagnosis and Treatment, Xinxiang Central Hospital, Xinxiang, China.

ORCID-Profile: Xiaohuan Li

Förderung

  • Clinical efficacy and prognosis of endoscopic mucosal dissection in the treatment of early gastric cancer and precancerous lesions

Zitieren

APA

Shen, F., Li, X., Qi, H., Yu, W., Liu, Y., & Guo, Z. (2026). MAGEA6 Promoted Gastric Cancer Progression by Activating Mitophagy. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70189

Vancouver

Shen F, Li X, Qi H, Yu W, Liu Y, Guo Z. MAGEA6 Promoted Gastric Cancer Progression by Activating Mitophagy. Molecular Carcinogenesis. 2026. doi:10.1002/mc.70189

BibTeX
@article{Shen2026,
  author = {Shen, Feifei and Li, Xiaohuan and Qi, Haili and Yu, Wei and Liu, Yuan and Guo, Zhanping},
  title = {MAGEA6 Promoted Gastric Cancer Progression by Activating Mitophagy},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  doi = {10.1002/mc.70189}
}
Kostenlos starten →